Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mTOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00811590
What this trial is testing

Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome

Who this might be right for
Peutz-Jeghers Syndrome
University of Utah 3
Not applicableUnknownNCT03129724
What this trial is testing

Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - Axitinib

Who this might be right for
Kidney Neoplasms
University Hospital, Strasbourg, France 100
Testing effectiveness (Phase 2)Study completedNCT00529802
What this trial is testing

Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer

Who this might be right for
Carcinoma, Renal Cell
University of Chicago 60
Early research (Phase 1)Study completedNCT00999882
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients

Who this might be right for
CancerAdvanced Hepatocellular Carcinoma
AstraZeneca 26
Not applicableActive Not RecruitingNCT04542733
What this trial is testing

The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient

Who this might be right for
Kidney Transplant InfectionBK Virus Infection
King Chulalongkorn Memorial Hospital 50
Early research (Phase 1)Study completedNCT01445106
What this trial is testing

A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors

Who this might be right for
Solid Tumors
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Study completedNCT02019693
What this trial is testing

The MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer

Who this might be right for
Kidney Cancer
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00891696
What this trial is testing

Nutritional and Contractile Regulation of Muscle Growth

Who this might be right for
Sarcopenia
The University of Texas Medical Branch, Galveston 144
Testing effectiveness (Phase 2)Ended earlyNCT02023905
What this trial is testing

Everolimus With and Without Temozolomide in Adult Low Grade Glioma

Who this might be right for
Low Grade GliomaWorld Health Organization (WHO) Grade II AstrocytomasOligodendrogliomas+1 more
University of California, San Francisco 27
Testing effectiveness (Phase 2)Ended earlyNCT02920450
What this trial is testing

Study of Paclitaxel, Carboplatin, and PF-05212384 in Advanced or Metastatic NSCLC (UF-STO-LUNG-002)

Who this might be right for
Non-Small Cell Lung Cancer
University of Florida 3
Not applicableLooking for participantsNCT06053671
What this trial is testing

Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue)

Who this might be right for
Focal Cortical DysplasiaEpilepsy
King's College Hospital NHS Trust 60
Early research (Phase 1)WithdrawnNCT01194193
What this trial is testing

Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours

Who this might be right for
CancerAdvanced Solid TumoursLymphomas
AstraZeneca 63
Testing effectiveness (Phase 2)Study completedNCT05835999
What this trial is testing

Everolimus Aging Study

Who this might be right for
AgingInsulin Resistance
University of Wisconsin, Madison 106
Early research (Phase 1)WithdrawnNCT02833506
What this trial is testing

Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma+18 more
Roswell Park Cancer Institute
Not applicableStudy completedNCT03091465
What this trial is testing

Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib

Who this might be right for
Metastatic Renal Cell Carcinoma
Spanish Oncology Genito-Urinary Group 530
Testing effectiveness (Phase 2)Study completedNCT02201212
What this trial is testing

Everolimus for Cancer With TSC1 or TSC2 Mutation

Who this might be right for
TSC1TSC2Tuberous Sclerosis Complex+1 more
Dana-Farber Cancer Institute 30
Early research (Phase 1)Ended earlyNCT03333694
What this trial is testing

Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

Who this might be right for
Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT00632268
What this trial is testing

Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer

Who this might be right for
Metastatic Gastric Cancer
National Taiwan University Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00926107
What this trial is testing

Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse

Who this might be right for
Ovarian Cancer
Hellenic Cooperative Oncology Group 9
Early research (Phase 1)Study completedNCT01316809
What this trial is testing

AZD8055 for Adults With Recurrent Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaAnaplastic Oligodendroglioma+2 more
National Cancer Institute (NCI) 22
Next Page